Tumor-seeking glucose-dendrons for the delivery of chemotherapeutics and imaging agent to cancer cells
AssigneeThe Board of Trustees of the University of Illinois
InventorsJefferson Kar Fai CHAN, Amanda EAST
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe Board of Trustees of the University of Illinois
InventorsJefferson Kar Fai CHAN, Amanda EAST
Estimating the term…
The attachment of glucose to drugs and imaging agents enables cancer cell targeting via interactions with GLUT1 overexpressed on the cell surface. The present technology describes a biomimetic approach for the design of a multivalent glucose moiety (mvGlu). We showcase the utility of this new group by developing aza-BODIPY-based contrast agents boasting a significant PA signal enhancement greater than 11-fold after spectral unmixing. Moreover, when applied to targeting cancer cells, effective staining could be achieved with ultra-low dye concentrations (50 nM) and compared to a non-targeted analog, the signal intensity was >1000-fold higher. Also, we employed the mvGlu technology to develop a logic-gated acoustogenic probe to detect intratumoral Cu(I), which is an emerging cancer biomarker, in a murine model of breast tumor. This application was not possible using other acoustogenic probes previously developed for copper sensing.
A compound represented by Formula I:
Dependencies are inferred from the claim text.